Stocks360

Wacker Chemie AG (WKCMF)

Stock analysis · OTC · Basic Materials · Chemicals - Specialty

Share: Facebook X WhatsApp SMS
$93.90

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$4.66B
PE (TTM)
-9.43
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.78
Day Range
$93.90 – $93.90
52-wk Range
$74.25 – $122.41
Avg Volume
N/A
Volume
100.00

Wacker Chemie AG (WKCMF) is a publicly traded company in the Basic Materials sector. Latest price: $93.90. Market cap $4.66B. Trailing PE -9.43. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $80.15 2026-10-29 · $93.90 (+17.16%)

Earnings

Most Recent
Jul 30, 2026
EPS $7.82 vs est. $0.41
Beat by $7.41
Next Earnings
Mar 8, 2027
EPS estimate $1.35

Proprietary Signals

Signal snapshot temporarily unavailable.

About Wacker Chemie AG

Wacker Chemie AG, an international chemical manufacturing group, delivers a wide array of chemical products across the globe through its various subsidiaries. The company structures its operations into four core divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones segment manufactures and supplies a broad spectrum of silicone-based materials, including silanes, siloxanes, silicone fluids, emulsions, elastomers, resins, and fumed silicas. These materials find extensive application within the construction, electronics, automotive, healthcare, and renewable energy industries. Wacker Polymers specializes in providing binders and polymeric additives, notably dispersible polymer powders and vinyl acetate-ethylene dispersions. These products are crucial for sectors such as building and construction, papermaking, adhesives, paints, coatings, and basic chemical production. Within Wacker Biosolutions, the company offers customized biotechnological solutions and catalog items for the fine chemical industry. Its portfolio encompasses pharmaceutical proteins, vaccines, cyclodextrins, cysteine, solid polyvinyl acetate resins, and acetyl…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-9.43×
P/S (TTM)0.75×
P/B1.03×
PEG0.01×
P/FCF (TTM)13.10×
EV / EBITDA10.17×
EV / Sales1.01×
Earnings Yield-10.44%
Free Cash Flow Yield7.64%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$5.57B
Revenue (TTM)$5.52B
Net Income (TTM)-$431.56M
Free Cash Flow (TTM)$859.98M
Net Debt$1.43B
Working Capital$2.63B
Gross Margin14.05%
Operating Margin1.34%
Net Margin-7.84%
Return on Equity-11.14%
Return on Invested Capital0.98%

Peers

Recent News

Related

Browse more tickers: sitemap